The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD
Attention Deficit Hyperactivity Disorder
About this trial
This is an interventional treatment trial for Attention Deficit Hyperactivity Disorder focused on measuring methylphenidate, executive functions, working memory, tDCS, inhibitory control
Eligibility Criteria
Criteria: Inclusion Criteria:
- Patients must receive a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) oriented diagnosis of ADHD and need drug treatment for the severity of symptoms;
- Intelligent Quotient (IQ) > 85;
Exclusion Criteria:
- Presence of Autism Spectrum Disorders;
- Presence of Mood Disorders;
- Previous/current diagnosis of neurological conditions (i.e. epilepsy, neurodegenerative diseases);
- Presence of Genetic Syndromes;
- Presence of basal medical conditions (i.e. heart, kidney or liver diseases) which may exclude the possibility to administer MPH.
Sites / Locations
- Bambino Gesù Hospital and Research Institute
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
anodal tDCS- sham tDCS- MPH
anodal tDCS- MPH- sham tDCS
sham tDCS- anodal tDCS- MPH
sham tDCS- MPH- anodal tDCS
MPH- anodal tDCS- sham tDCS
MPH- sham tDCS- anodal tDCS
(A) anodal tDCS at t1 (B) sham tDCS at t2 (C) MPH at t3
(A) anodal tDCS at t1 (C) MPH at t2 (B) sham tDCS at t3
(B) sham tDCS at t1 (A) anodal tDCS at t2 (C) MPH at t3
(B) sham tDCS at t1 (C) MPH at t2 (A) anodal tDCS at t3
(C) MPH at t1 (A) anodal tDCS at t2 (B) sham tDCS at t3
(C) MPH at t1 (B) sham tDCS at t2 (A) anodal tDCS at t3